Health-related quality of life (HRQOL) and patient-centered outcomes with maintenance olaparib compared with placebo following chemotherapy in patients with germline (g) BRCA-mutated (m) platinum-sensitive relapsed serous ovarian cancer (PSR SOC): SOLO2 phase III trial

Michael Friedlander, Val Gebski, Emma Gibbs, Ralph Bloomfield, Felix Hilpert, Lari B Wenzel, Florence Joly, Daniel Eek, Manuel Rodrigues, Andrew R Clamp, Richard T Penson, Diane M Provencher, Jacob Korach, Tomasz Huzarski, Laura Vidal, Vanda Salutari, Clare L Scott, Maria Ornella Nicoletto, Kenji Tamura, Eric Pujade-Lauraine